《光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识》解读

贾海波; 何路平; 徐艺硕; 于波

doi:10.13201/j.issn.1001-1439.2023.03.002

《光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识》解读

- 1.
  哈尔滨医科大学附属第二医院心内科(哈尔滨，150086)
- 2.
  心肌缺血教育部重点实验室

详细信息

通讯作者: 于波，E-mail：yubodr@163.com

中图分类号: R541.4

收稿日期: 2022-11-01

刊出日期: 2023-03-13

Interpretation of Chinese expert consensus on the application of optical coherence tomography in the interventional diagnosis and treatment of coronary artery disease

- 1.
  Department of Cardiology, The 2nd Affiliated Hospital of Harbin Medical University, Harbin, 150086, China
- 2.
  The Key Laboratory of Myocardial Ischemia, Chinese Ministry of Education

More Information

Corresponding author: YU Bo, E-mail: yubodr@163.com

Received Date: 01 November 2022

Publish Date: 13 March 2023

摘要

摘要: 光学相干断层成像技术(OCT)在冠状动脉介入治疗中具有重要的指导价值，但OCT在我国仍存在使用率较低且使用不规范的问题。2023年2月，中华医学会心血管病学分会发布了《光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识》，主要围绕OCT的临床应用指征，OCT如何指导临床决策、支架置入及结果优化，OCT在不同病变和人群中的指导价值等内容达成共识。为了更好地理解专家共识、规范OCT的临床应用，本文将对其核心内容进行解读。
- 冠心病 /
- 光学相干断层成像技术 /
- 冠状动脉介入治疗 /
- 专家共识 /
- 解读
Abstract: Optical coherence tomography(OCT) plays an important role in guiding percutaneous coronary interventions. In spite of this, the adoption of OCT remains limited in routine clinical practice and lack of standards in China. In Feb 2023, Chinese Society of Cardiology issued the "Chinese expert consensus on the application of optical coherence tomography in the interventional diagnosis and treatment of coronary artery disease", which mainly focus on clinical indication, the impact of OCT on planning procedural strategy, optimization stent implantation and percutaneous coronary intervention result and the value of OCT in different patients or lesions. In order to better understand the expert consensus and standardize the clinical practice of OCT, this paper interprets its core contents.
- coronary artery disease /
- optical coherence tomography /
- coronary interventions /
- expert consensus /
- interpretation

HTML全文

参考文献(23)

[1]	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 光学相干断层成像技术在冠心病介入诊疗中应用的中国专家共识[J]. 中华心血管病杂志, 2023, 51(2) : 109-124. doi: 10.3760/cma.j.cn112148-20220602-00436
[2]	Lawton JS, Tamis-Holland JE, Bangalore S, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines[J]. Circulation, 2022, 145(3): e18-e114.
[3]	Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization[J]. Eur Heart J, 2019, 40(2): 87-165. doi: 10.1093/eurheartj/ehy394
[4]	Ibanez B, James S, Agewall S, et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology(ESC)[J]. Eur Heart J, 2018, 39(2): 119-177. doi: 10.1093/eurheartj/ehx393
[5]	Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation[J]. Eur Heart J, 2021, 42(14): 1289-1367. doi: 10.1093/eurheartj/ehaa575
[6]	Stefanini GG, Alfonso F, Barbato E, et al. Management of myocardial revascularisation failure: an expert consensus document of the EAPCI[J]. EuroIntervention, 2020, 16(11): e875-e890. doi: 10.4244/EIJ-D-20-00487
[7]	Räber L, Mintz GS, Koskinas KC, et al. Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions[J]. Eur Heart J, 2018, 39(35): 3281-3300. doi: 10.1093/eurheartj/ehy285
[8]	Wijns W, Shite J, Jones MR, et al. Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I study[J]. Eur Heart J, 2015, 36(47): 3346-3355. doi: 10.1093/eurheartj/ehv367
[9]	Ali ZA, Maehara A, Généreux P, et al. Optical coherence tomography compared with intravascular ultrasound and with angiography to guide coronary stent implantation(ILUMIEN Ⅲ: OPTIMIZE PCI): a randomised controlled trial[J]. Lancet, 2016, 388(10060): 2618-2628. doi: 10.1016/S0140-6736(16)31922-5
[10]	Jones DA, Rathod KS, Koganti S, et al. Angiography Alone Versus Angiography Plus Optical Coherence Tomography to Guide Percutaneous Coronary Intervention: Outcomes From the Pan-London PCI Cohort[J]. JACC Cardiovasc Interv, 2018, 11(14): 1313-1321. doi: 10.1016/j.jcin.2018.01.274
[11]	Meneveau N, Souteyrand G, Motreff P, et al. Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study(Does Optical Coherence Tomography Optimize Results of Stenting)[J]. Circulation, 2016, 134(13): 906-917. doi: 10.1161/CIRCULATIONAHA.116.024393
[12]	Lee SY, Kim JS, Yoon HJ, et al. Early Strut Coverage in Patients Receiving Drug-Eluting Stents and its Implications for Dual Antiplatelet Therapy: A Randomized Trial[J]. JACC Cardiovasc Imaging, 2018, 11(12): 1810-1819. doi: 10.1016/j.jcmg.2017.12.014
[13]	Chamié D, Costa JR Jr, Damiani LP, et al. Optical Coherence Tomography Versus Intravascular Ultrasound and Angiography to Guide Percutaneous Coronary Interventions: The iSIGHT Randomized Trial[J]. Circ Cardiovasc Interv, 2021, 14(3): e009452. doi: 10.1161/CIRCINTERVENTIONS.120.009452
[14]	Croce K, Wollmuth J, Mathew R, et al. LightLab study[R]. EuroPCR, 2020.
[15]	Leistner DM, Riedel M, Steinbeck L, et al. Real-time optical coherence tomography coregistration with angiography in percutaneous coronary intervention-impact on physician decision-making: The OPTICO-integration study[J]. Catheter Cardiovasc Interv, 2018, 92(1): 30-37. doi: 10.1002/ccd.27313
[16]	Jia H, Dai J, Hou J, et al. Effective anti-thrombotic therapy without stenting: intravascular optical coherence tomography-based management in plaque erosion(the EROSION study)[J]. Eur Heart J, 2017, 38(11): 792-800.
[17]	Jia H, Dai J, He L, et al. EROSION Ⅲ: A Multicenter RCT of OCT-Guided Reperfusion in STEMI With Early Infarct Artery Patency[J]. JACC Cardiovasc Interv, 2022, 15(8): 846-856. doi: 10.1016/j.jcin.2022.01.298
[18]	Haddad K, Tanguay JF, Potter BJ, et al. Longer Inflation Duration and Predilation-Sizing-Postdilation Improve Bioresorbable Scaffold Outcomes in a Long-term All-Comers Canadian Registry[J]. Can J Cardiol, 2018, 34(6): 752-758. doi: 10.1016/j.cjca.2018.02.030
[19]	Ortega-Paz L, Capodanno D, Gori T, et al. Predilation, sizing and post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffold implantation for prediction of cardiac adverse events: development and internal validation of the PSP score[J]. EuroIntervention, 2017, 12(17): 2110-2117. doi: 10.4244/EIJ-D-16-00974
[20]	Jeger RV, Eccleshall S, Wan Ahmad WA, et al. Drug-Coated Balloons for Coronary Artery Disease: Third Report of the International DCB Consensus Group[J]. JACC Cardiovasc Interv, 2020, 13(12): 1391-1402. doi: 10.1016/j.jcin.2020.02.043
[21]	Li L, Zhao L, Wang J, et al. Optical coherence tomography-guided drug coated balloon in non-small de novo coronary artery lesions: a prospective clinical research[J]. Am J Transl Res, 2021, 13(10): 11617-11624.
[22]	Adriaenssens T, Joner M, Godschalk TC, et al. Optical Coherence Tomography Findings in Patients With Coronary Stent Thrombosis: A Report of the PRESTIGE Consortium(Prevention of Late Stent Thrombosis by an Interdisciplinary Global European Effort)[J]. Circulation, 2017, 136(11): 1007-1021. doi: 10.1161/CIRCULATIONAHA.117.026788
[23]	Souteyrand G, Amabile N, Mangin L, et al. Mechanisms of stent thrombosis analysed by optical coherence tomography: insights from the national PESTO French registry[J]. Eur Heart J, 2016, 37(15): 1208-1216. doi: 10.1093/eurheartj/ehv711